Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2025-08-25 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
2025年半年度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (297 characters) indicating that the company's 2025 half-year report has been published and is available on official websites. It does not contain the actual half-year financial report or substantive financial data, but rather directs investors to where the report can be found. According to the 'MENU VS MEAL' rule, such a brief notice about report availability is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2025-08-25 Chinese
中国银河证券股份有限公司关于瑞普生物股份有限公司使用闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from China Galaxy Securities Co., Ltd. regarding the use of idle raised funds by Ruipu Bio Co., Ltd. for cash management. It includes specifics about the raised funds, investment projects, board and supervisory committee approvals, risk control measures, and compliance with Shenzhen Stock Exchange rules. The document is not a financial report like an annual or interim report, nor is it a simple announcement. It is a formal audit or verification opinion related to the use of raised funds, which fits the category of an Audit Report / Information (AR). The length and content confirm it is a substantive report, not just an announcement or certification. Therefore, the correct classification is AR with high confidence. Q3 2025
2025-08-25 Chinese
2025年半年度募集资金存放与使用情况专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2025 Half-Year Special Report on the Deposit and Use of Raised Funds" by 瑞普生物股份有限公司. It details the amount of funds raised, their deposit, usage, management, and investment projects related to the raised funds. The document references regulatory rules from the China Securities Regulatory Commission and Shenzhen Stock Exchange, and includes detailed financial figures and project progress for the half-year period ending June 30, 2025. The content is focused on the specific use and management of capital raised by the company, not a general financial report or earnings release. This matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length (8564 characters) and detailed financial data confirm it is a substantive report, not merely an announcement or certification. Therefore, the appropriate classification is CAP.
2025-08-25 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Ruipu Bio Co., Ltd. It details the meeting held on August 22, 2025, including approvals of various reports and proposals such as the 2025 semi-annual report, fundraising usage report, and cash management proposals. The document does not contain the actual semi-annual report or financial statements but references where these reports can be found online. The document is a formal announcement of meeting resolutions rather than the report itself. Given the nature and length (1758 characters), it fits best as a Regulatory Filing (RNS) since it is a formal disclosure of supervisory board meeting decisions and approvals without substantive financial data or full report content.
2025-08-25 Chinese
关于使用闲置自有资金购买理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 瑞普生物股份有限公司 regarding the use of idle funds to purchase financial products. It details the investment purpose, types, limits, risk analysis, board approval, and supervisory opinions. The content focuses on informing shareholders and the market about a financing-related decision involving the company's capital management. There are no financial statements, earnings data, or detailed financial reports included. The document is not a report itself but an announcement of a capital/financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 2540 characters, which is consistent with an announcement rather than a full report.
2025-08-25 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2025 年半年度报告摘要' which translates to '2025 Semi-Annual Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also includes shareholder information and notes on audit opinions and dividend plans. The document is a summary of the half-year report, indicating it is a financial report for a period shorter than a full fiscal year. The length is 2879 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.